Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS)

Neurology

Volumn 62, Issue 10, 2004, Pages 1753-1757

  Kaufmann, P ^a,b   Pullman, S L ^a   Shungu, D C ^a   Chan, S ^a   Hays, A P ^a   Del Bene, M L ^a   Dover, M A ^a   Vukic, M ^a   Rowland, L P ^a   Mitsumoto, H ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CORRELATION FUNCTION; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOTONEURON; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 2442660249     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000125182.17874.59     Document Type: Article

References (35)

1. Rowland LP. Diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1998;160:S6-S24.
2. Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases. Amyotroph Lateral Scler 2000;1:293-299.
3. Lawyer T, Netsky MG. Amyotrophic lateral sclerosis: a clinicoanatomic study of fifty-three cases. Arch Neurol Psychiatry 1953;69:171-192.
4. Brownell B, Oppenheimer D, Trevor-Hughes J. The central nervous system in motor neurone disease. J Neurol Nerosurg Psychiatry 1970; 33:338-357.
5. Iwanaga K, Hayashi S, Oyake M, et al. Neuropathology of sporadic amyotrophic lateral sclerosis of long duration. J Neurol Sci 1997;146: 139-143.
6. Leung DK, Hays AP, Geysu K, DelBene ML, Rowland LP. Diagnosis of ALS: clinicopathologic analysis of 76 autopsies. Neurology 1999; 52(suppl 2):A164.
7. Ince PG, Evans J, Knopp M, Forster G, et al. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology 2003;60:1252-1258.
8. Pioro EP, Antel JP, Cashman NR, et al. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology 1994;44:1933-1938.
9. Jones AP, Gunawardena WJ, Coutinho CMA, et al. Preliminary results of proton magnetic resonance spectroscopy in motor neuron disease (amyotrophic lateral sclerosis) J Neurol Sci 1995;129(suppl):85-89.
10. Giroud M, Walker P, Bernard D, et al. Reduced brain N-acetylaspartate in frontal lobes suggests neuronal loss in patients with amyotrophic lateral sclerosis. Neurol Res 1996;18:241-243.
11. Rooney WE, Miller RG, Gelinas D, et al. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology 1998;50: 1800-1805.
12. Block W, Karitzky J, Traber F, et al. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease. Arch Neurol 1998;55:931-936.
13. 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. J Neurol Sci 1999;169: 84-86.
14. Chan S, Shungu D, Douglas-Akinwande A, Lange DJ, Rowland LP. Motor neuron diseases; comparison of single voxel proton magnetic resonance spectroscopy of the motor cortex with magnetic resonance imaging of the brain. Radiology 1999;212:763-769.
15. Bowen BC, Pattany PM, Bradley WG, et al. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 2000;21:647-658.
16. Pohl C, Block W, Karitzky J, et al. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol 2001;58:729-735.
17. Schulte-Mattler WJ, Müller T, Zierz St. Transcranial magnetic stimulation compared with upper motor neuron signs in patients with amyotrophic lateral sclerosis. J Neurol Sci 1999;170:51-56.
18. Pouget J, Trefouret S, Attarian S. Transcranial magnetic stimulation (TMS): compared sensitivity of different motor response parameters in ALS. Amyotroph Lateral Scler 2000;1(suppl 2):S45-S49.
19. Pohl C, Block W, Traber F, et al. Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients. J Neurol Sci 2001;190:21-27.
20. Mills KR, Nithi KA. Peripheral and central motor conduction in amyotrophic lateral sclerosis. J Neurol Sci 1998;159:82-87.
21. Miscio G, Pisano F, Mora G, Mazzini L. Motor neuron disease: usefulness of transcranial magnetic stimulation in improving the diagnosis. Clin Neurophysiol 1999;110:975-981.
22. Triggs WJ, Menkes D, Onorato J, et al. Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron disease. Neurology 1999;53:605-611.
23. Berardelli A, Inghilleri M, Formisano R, Accornero N, Manfredi M. Stimulation of motor tracts in motor neuron disease. J Neurol Neurosurg Psychiatry 1987;50:732-737.
24. Younger DS, Rowland LP, Latov N, et al. Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes. Neurology 1990;40:595-599.
25. Shibata N, Nagai R, Uchida K, et al. Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Res 2001;917:97-104.
26. 1H-MRS evidence of neurodegeneration and excess glutamate and glutamine in ALS medulla Neurology 1999;53:71-79.
27. Cwik VA, Hanstock CC, Allen PS, et al. Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy. Neurology 1998;50:72-77.
28. 1H MRSI in amyotrophic lateral sclerosis. Magn Res Med 2001;45:513-516.
29. Kalra S, Cashman NR, Genge A, Arnold DL. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 1998;X:1757-1761.
30. Dechent P, Pouwels PJW, Wilken B, Hanefeld F, Frahm J. Increase of total creatine in human brain after oral supplementation of creatinemonohydrate. Am J Physiol 1999;277:R698-R704.
31. Vielhaber S, Kaufmann J, Kanowski M, et al. Effect of creatine supplementation on metabolite levels in ALS motor cortices. Exp Neurol 2001; 172:377-382.
32. Gredal O, Rosenbaum S, Topp S, et al. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy. Neurology 1997;48:878-881.
33. Sarchielli P, Pelliccioli GP, Tarducci R, et al. Magnetic resonance imaging and 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. Neuroradiology 2001;43:189-197.
34. Bowen BC, Pattany PM, Bradley WG, et al. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 2000;21:647-658.
35. Eisen A, Weber M. Neurophysiological evaluation of cortical function in the early diagnosis of ALS. Amyotroph Lat Scler 2000;1:S47-S51.